LHC Group, Inc. (NASDAQ:LHCG) has been upgraded to Hold in a statement by Zacks Investment Research earlier today.
- Updated: October 8, 2016
Boasting a price of $37.56, LHC Group, Inc. (NASDAQ:LHCG) traded -1.13% lower on the day. With the last close down -8.16% from the two hundred day average, compared with the S&P 500 Index which has decreased -0.01% over the date range. LHC Group, Inc. has recorded a 50-day average of $36.61 and a two hundred day average of $40.01. Volume of trade was down over the average, with 91,351 shares of LHCG changing hands under the typical 122,048
Zacks Investment Research has upgraded LHC Group, Inc. (NASDAQ:LHCG) to Hold in a statement released on 10/05/2016.
On 8/07/2015, Piper Jaffray released a statement on LHC Group, Inc. (NASDAQ:LHCG) bumped up the target price from $38.00 to $52.00 that suggested an upside of 0.05%.
With a total market value of $0, LHC Group, Inc. has 52 week low of $32.77 and a 52 week high of $49.34 with a PE ratio of 19.24 .
Brief Synopsis On LHC Group, Inc. (NASDAQ:LHCG)
LHC Group, Inc. is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services. Through its home health services segment, the Company offers a range of services, including skilled nursing, medically-oriented social services, and physical, occupational and speech therapy. Through its hospice services segment, the Company offers a range of services, including pain and symptom management, emotional and spiritual support, inpatient and respite care, homemaker services and counseling. The Company's community-based service operations offer a range of services to patients in their home or in a medical facility. The Company provides facility-based services principally through its LTACHs.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.